Divine Daze
A lesser-known hybrid strain with sparse public data, often marketed as a relaxing evening cultivar with limited verifiable lineage records.
Divine Daze is one of countless boutique strain names floating around dispensary menus and seed listings with almost no verifiable provenance. There are no peer-reviewed chemotype analyses of it, no breeder records in major databases, and the lineage stories vary by vendor. Anything you read about its 'effects' is marketing copy or user anecdote, not science. If you enjoy it, great — but treat specific claims about THC percentages, terpene profiles, or predictable effects as unverified until your specific batch is lab-tested.
Overview
Divine Daze is a strain name that appears on some dispensary menus and informal seed exchanges, but it lacks the documented breeder history, repeated lab testing, or cultivation literature that better-known cultivars have. Unlike strains tracked across multiple licensed markets, there is no central record of who first released Divine Daze, when, or from what parents No data.
Because cannabis strain names are not trademarked or standardized, two products sold as 'Divine Daze' in different states or countries may be genetically unrelated [1][2]. This is true for the majority of named cultivars, but it matters especially for obscure ones where consumers cannot cross-check against widely available chemotype data.
Chemistry: cannabinoids and terpenes
There is no published, peer-reviewed cannabinoid or terpene profile specific to Divine Daze No data. Vendor listings sometimes cite THC values in the high teens to low twenties, but these are self-reported and not standardized across labs.
What we can say generally: most modern hybrid flower on legal markets tests between roughly 15–25% THC with CBD under 1% [3]. Terpene totals usually fall between 0.5% and 2.5% of dry weight, with myrcene, caryophyllene, limonene, and pinene being the most common dominant terpenes across the commercial gene pool [4]. Without a verified COA (certificate of analysis) for a specific Divine Daze batch, any more specific number is guesswork.
If you want to know what's actually in the jar in front of you, the only reliable answer is the lab test for that batch — not the strain name.
Reported effects
Vendor descriptions typically frame Divine Daze as relaxing or sedating, sometimes pitched for evening use Anecdote. These descriptions are marketing summaries of user reviews, not clinical findings.
A few important caveats:
- There are no strain-specific clinical trials for Divine Daze or, in fact, for the overwhelming majority of named cannabis cultivars [5].
- The popular idea that 'indica' predicts sedation and 'sativa' predicts stimulation is not supported by chemotype data; the indica/sativa split as used on menus does not reliably map to the plant's chemistry or effects [6][7] Disputed.
- Individual response to cannabis varies widely based on dose, tolerance, route of administration, setting, and the user's own endocannabinoid biology [8].
In other words: how Divine Daze feels for you is more about dose and personal physiology than about the name on the label.
Lineage
The lineage of Divine Daze is not consistently documented. Different vendors and forums attribute it to different parent crosses, and we could not find a verified breeder release that matches the name No data.
This is common for boutique strain names. Because there is no registry of cannabis genetics analogous to plant variety protection schemes for other crops in most jurisdictions, breeders, growers, and retailers can use a name without proving its parentage [1]. Genetic studies have repeatedly shown that strains sharing a name often differ genetically, and strains with different names are sometimes nearly identical [2].
Treat any specific lineage claim about Divine Daze as unverified unless the seller can produce breeder documentation or genetic testing.
Cultivation basics
There is no authoritative grow guide for Divine Daze No data. The general principles that apply to most photoperiod hybrid cannabis cultivars are:
- Flowering: 8–10 weeks indoors under a 12/12 light schedule is typical for modern hybrids [9].
- Environment: temperatures around 20–28°C with relative humidity dropping from ~60% in veg to 40–50% in late flower to reduce mold risk [9].
- Nutrition: standard cannabis-specific feeding schedules; no published data suggests Divine Daze has unusual nutrient needs.
- Training: topping, low-stress training, or SCROG can improve yield in indoor settings for most hybrids.
If you are sourcing seeds or clones labeled 'Divine Daze', ask the supplier for parentage documentation and, ideally, a recent COA from a previous harvest. Without that, you are buying a name, not a known genetic.
Marketing vs. reality
A few common marketing claims worth flagging:
- 'Divine Daze is an indica-dominant hybrid that produces a deeply relaxing body high.' This is a marketing template applied to thousands of strains. Without chemotype data and controlled studies, it is not a verifiable claim about this specific cultivar Anecdote.
- 'High in myrcene, which is why it's sedating.' The widely repeated claim that myrcene above 0.5% causes a 'couch-lock' indica effect is folklore that traces to unsourced industry talking points, not peer-reviewed pharmacology [10] Disputed. See Myrcene for more.
- 'Pure genetics from [famous parent strain].' Without breeder records or genetic testing, this is unverifiable [1][2].
None of this means Divine Daze is a bad product — it may well be excellent flower. It means the story attached to it carries far less information than the lab test for the specific batch you are buying.
Sources
- Peer-reviewed Sawler, J. et al. (2015). The genetic structure of marijuana and hemp. PLoS ONE, 10(8), e0133292.
- Peer-reviewed Schwabe, A.L. & McGlaughlin, M.E. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 1(1), 3.
- Peer-reviewed Smart, R. et al. (2017). Variation in cannabis potency and prices in a newly legal market. Addiction, 112(12), 2167–2177.
- Peer-reviewed Hazekamp, A. et al. (2016). Cannabis: from cultivar to chemovar II — a metabolomics approach to cannabis classification. Cannabis and Cannabinoid Research, 1(1), 202–215.
- Government National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
- Peer-reviewed Piomelli, D. & Russo, E.B. (2016). The Cannabis sativa versus Cannabis indica debate: an interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44–46.
- Peer-reviewed Watts, S. et al. (2021). Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants, 7, 1330–1334.
- Peer-reviewed MacCallum, C.A. & Russo, E.B. (2018). Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine, 49, 12–19.
- Book Cervantes, J. (2015). The Cannabis Encyclopedia: The Definitive Guide to Cultivation & Consumption of Medical Marijuana. Van Patten Publishing.
- Peer-reviewed Russo, E.B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...